GelStat Corp. (OTCMKTS:GSAC – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 3,449 shares. Based on an average daily trading volume, of 916,991 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
GelStat Price Performance
Shares of GSAC stock remained flat at $0.00 on Friday. GelStat has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms.
Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms.
Further Reading
- Five stocks we like better than GelStat
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
